You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Details for Patent: 8,814,834


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,814,834 protect, and when does it expire?

Patent 8,814,834 protects OTREXUP and is included in one NDA.

This patent has nine patent family members in five countries.

Summary for Patent: 8,814,834
Title:Injector safety device
Abstract: A safety member for use with an injection device is disclosed. The safety member includes a blocking ring extending into a housing of the injection device in blocking association with a latch member associated with a trigger mechanism of the injector, in which the blocking ring blocks movement of a portion of the trigger mechanism into a firing position. The safety member further includes a manipulable portion disposed outside the housing and configured for hand-manipulation by a user to remove the safety member from the housing to unblock the firing mechanism to enable firing of the injector.
Inventor(s): Sund; Julius (Plymouth, MN), Lagman; Eric (Anderson, SC), Hoeft; Peter (Franconia, MN), Lesch, Jr.; Paul R. (Lino Lakes, MN), Kramer; Tom (Coon Rapids, MN)
Assignee: Antares Pharma, Inc. (Ewing, NJ)
Application Number:12/921,940
Patent Claim Types:
see list of patent claims
Use; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,814,834: A Comprehensive Analysis

Introduction

When delving into the specifics of a patent, such as United States Patent 8,814,834, it is crucial to understand the broader context of patent law, the tools available for patent searches, and the intricacies of patent claims and scope. This article will guide you through the process of analyzing a patent, focusing on the scope and claims of US Patent 8,814,834.

The Role of the USPTO

The United States Patent and Trademark Office (USPTO) is the central agency responsible for granting U.S. patents and registering trademarks. Understanding the resources provided by the USPTO is essential for conducting thorough patent searches and analyses[2].

Tools for Patent Searches

Patent Public Search

The USPTO offers the Patent Public Search tool, a modern and powerful application that replaced legacy search tools. This tool provides enhanced access to prior art and allows users to select from two modern interfaces, improving the overall patent searching process[1].

Global Dossier

The Global Dossier service allows users to access file histories of related applications from participating IP Offices, including the IP5 Offices. This service is invaluable for seeing the patent family for a specific application and accessing dossier, classification, and citation data[1].

Public Search Facility and PTRCs

The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) offer additional resources for patent searches. Trained staff at these facilities can assist in using local search resources and provide training in patent search techniques[1].

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention. The USPTO provides detailed datasets on patent claims, such as the Patent Claims Research Dataset, which contains information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014[3].

Types of Patent Claims

  • Independent Claims: These claims stand alone and do not depend on other claims.
  • Dependent Claims: These claims refer back to and further limit another claim or claims in the same patent.
  • Method Claims: These claims describe a process or method.
  • Apparatus Claims: These claims describe a device or system.

Analyzing the Scope of a Patent

The scope of a patent is determined by its claims. Here are some key points to consider:

Claim Construction

Claim construction is the process of interpreting the meaning of the words used in the claims. This is crucial for determining the scope of the patent and can be a point of contention in patent litigation.

Patent Scope Measurements

The USPTO has developed measures of patent scope, such as those detailed in the Patent Claims Research Dataset. These measures help in understanding the breadth and depth of the patent's protection[3].

Case Study: US Patent 8,814,834

To illustrate the analysis, let's consider US Patent 8,814,834.

Patent Details

  • Title: The title of the patent provides a brief description of the invention.
  • Abstract: The abstract gives a concise summary of the invention.
  • Claims: The claims section is where the legal boundaries of the invention are defined.
  • Description: The detailed description section explains the invention in more detail.

Claim Analysis

  • Independent Claims: Identify the independent claims, which are typically broader and more significant.
  • Dependent Claims: Analyze the dependent claims to see how they narrow down the invention.
  • Claim Language: Pay attention to the specific language used in the claims, as it can significantly impact the scope of the patent.

Prior Art and Citations

Using tools like the Common Citation Document (CCD), you can see the prior art cited by all participating offices for the family members of the patent application. This helps in understanding how the patent fits into the broader patent landscape[1].

Practical Steps for Analysis

Step 1: Locate the Patent

Use the Patent Public Search tool or other resources like the USPTO Public Search Facility to locate the patent.

Step 2: Read the Claims

Carefully read through the claims section to understand the legal boundaries of the invention.

Step 3: Analyze the Description

Review the detailed description to gain a deeper understanding of the invention and how it is implemented.

Step 4: Check Prior Art and Citations

Use the CCD or other tools to see the prior art and citations related to the patent.

Step 5: Evaluate the Scope

Determine the scope of the patent by interpreting the claims and understanding how they relate to the prior art.

Industry Expert Insights

Industry experts often emphasize the importance of thorough patent searches and claim analysis. For example, Alan Marco, former Chief Economist for the USPTO, has highlighted the complexity of patent scope measurements and the need for detailed datasets to understand patent claims[3].

Statistics and Trends

  • Allowance Rates: Studies have shown that the allowance rates for patent applications can vary significantly. For instance, the first-action allowance rate, progenitor allowance rate, and family allowance rate provide different insights into the likelihood of a patent being granted[4].
  • Continuation Applications: The use of continuation applications can complicate the calculation of allowance rates but is a common strategy in patent prosecution[4].

Legal and Policy Considerations

The legal and policy landscape surrounding patents is constantly evolving. For example, discussions around the establishment of a small claims patent court highlight the need for more accessible and efficient dispute resolution mechanisms in patent law[5].

Key Takeaways

  • Thorough Search: Conduct a thorough patent search using tools like the Patent Public Search and Global Dossier.
  • Claim Analysis: Carefully analyze the claims to understand the scope of the patent.
  • Prior Art: Review prior art and citations to place the patent in the broader patent landscape.
  • Expert Insights: Consider insights from industry experts and legal practitioners.
  • Legal Considerations: Stay updated on legal and policy changes that could impact patent law.

FAQs

Q: How do I locate a specific patent using USPTO resources?

A: You can use the Patent Public Search tool or visit the USPTO Public Search Facility to locate a specific patent.

Q: What is the difference between independent and dependent claims?

A: Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit another claim.

Q: How do I determine the scope of a patent?

A: The scope of a patent is determined by interpreting the claims and understanding how they relate to the prior art.

Q: What is the Common Citation Document (CCD), and how is it useful?

A: The CCD provides a single point of access to up-to-date citation data relating to the patent applications of the IP5 Offices, helping to visualize search results on a single page.

Q: Why is it important to check prior art and citations?

A: Checking prior art and citations helps in understanding how the patent fits into the broader patent landscape and can impact the validity and scope of the patent.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. U.S. Patent and Trademark Office (USPTO) | USAGov: https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims Research Dataset - USPTO: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. What Is the Probability of Receiving a US Patent?: https://yjolt.org/sites/default/files/carley_hegde_marco-what_is_the_probability_of_receiving_a_us_patent_0.pdf
  5. U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,814,834

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Otter Pharms OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-005 Nov 7, 2014 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Otter Pharms OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-001 Oct 11, 2013 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Otter Pharms OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-006 Mar 24, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Otter Pharms OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-002 Oct 11, 2013 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Otter Pharms OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-007 Mar 24, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,814,834

PCT Information
PCT FiledMarch 10, 2009PCT Application Number:PCT/US2009/036682
PCT Publication Date:September 17, 2009PCT Publication Number: WO2009/114542

International Family Members for US Patent 8,814,834

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2718053 ⤷  Subscribe
European Patent Office 2268342 ⤷  Subscribe
European Patent Office 2990067 ⤷  Subscribe
European Patent Office 3636301 ⤷  Subscribe
Spain 2548447 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.